COVID-19
-
Researchers launch study into COVID-19 vaccine uptake and efficacy in vulnerable urban populations
In this Q&A, Dr. Brittany Barker, postdoctoral fellow with UBC’s department of medicine and research scientist at BCCSU, and Dr. Hudson Reddon, postdoctoral research fellow with UBC’s department of medicine, discuss how COVID-19 and vaccinations are being experienced by vulnerable populations.
-
UBC research shows wastewater genomic testing can effectively track COVID-19 variants of concern within a region
Wastewater testing can accurately and rapidly identify levels of COVID-19 infections in the community, including the rise of variants of concern, suggests new research led by UBC professor Dr. Ryan Ziels.
-
Study highlights pandemic impact on adolescent mental health
Adolescents who were in a good headspace before COVID-19 suffered a decline during the pandemic, whereas those with poor mental health fared better, according to new research.
-
Pandemic underlines need to address physician burnout, study finds
Two out of three Vancouver physicians surveyed in a new UBC study faced burnout during the COVID-19 pandemic.
-
Transition plan for return to campus
UBC is outlining its phased approach to support faculty and staff returning to campus in preparation for the 2021/22 Winter Session starting in September
-
Researchers launch COVID-19 vaccine registry for pregnant and breastfeeding individuals in Canada
As the COVID-19 vaccine rollout ramps up across the country, the risks and benefits of immunization for pregnant and breastfeeding people remain largely unknown because the initial vaccine clinical trials did not include these populations.
-
Debunking COVID-19 myths: As the weather warms, UBC vaccine expert separates fact from fiction
Dr. Anna Blakney, assistant professor in UBC’s School of Biomedical Engineering, Michael Smith Laboratories and vaccine expert, addresses some popular myths about COVID-19.
-
Canadian researchers lead development and testing of promising treatment for COVID-19 variants
A new anti-viral drug could improve COVID-19 outcomes and survival rates — and is highly effective against multiple variants — according to a new study led by researchers at the University of British Columbia and Université de Sherbrooke.
-
UBC researchers unveil first molecular images of B.1.1.7 COVID-19 mutation
UBC researchers are the first in the world to publish structural images of the N501Y mutation on the SARS-CoV-2 spike protein—a change believed to be partly responsible for the highly infectious nature and rapid spread of variant B.1.1.7.
